Effective Lenvatinib Treatment Complicated with Secondary Tracheocutaneous Fistula in Patients with Advanced Anaplastic Thyroid Carcinoma Wen-Chi Wu et al, 2019, Reports CrossRef
Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer
Xi Su et al, 2020, OncoTargets and Therapy CrossRef
Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis Takaaki Oba et al, 2020, Endocrine Journal CrossRef
A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant Chemotherapy Hiroyuki Iwasaki et al, 2020, Case Reports in Endocrinology CrossRef
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment Pascal K. C. Jonker et al, 2021, Annals of Surgical Oncology CrossRef
Multikinase Inhibitor Treatment in Thyroid Cancer Ole Vincent Ancker et al, 2019, International Journal of Molecular Sciences CrossRef
Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Carcinoma: A Meta-Analysis Dongmei Huang et al, 2022, Frontiers in Endocrinology CrossRef
Lenvatinib vs. palliative therapy for stage IVC anaplastic thyroid cancer Hiroyuki Iwasaki et al, 2019, Molecular and Clinical Oncology CrossRef
Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies Bo-Hua Kuang et al, 2024, Frontiers in Endocrinology CrossRef
Treatment of anaplastic thyroid cancer with tyrosine kinase inhibitors targeted on the tumor vasculature: initial experience in clinical practice Sae Ishihara et al, 2021, Endocrine Journal CrossRef
Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis Soo Young Kim et al, 2020, Frontiers in Endocrinology CrossRef